Human Airway Epithelial Cell Line Responses to Cigarette Smoke Extract and LPS: Insights Into Mucus and Cytokine Regulation
Fundamental & Clinical Pharmacology · 2026-11 · 40 (6)
DOI: 10.1111/fcp.70117 ↗Abstract
ABSTRACT Background Airway epithelial cells produce mucus to protect themselves against toxic agents and pathogens. However, excessive mucus accumulation, as seen in chronic obstructive pulmonary disease (COPD), contributes to airway obstruction, inflammation, and reduced efficacy of inhaled therapies. Objectives The aim of the study was to develop an in vitro model for evaluating cytokine production and mucus secretion in human airway epithelial cell lines, with potential application for drug screening. Methods Three human airway epithelial cell lines (A549, Calu‐3, and NCI‐H292) were stimulated for 24 h with cigarette smoke extract (CSE), alone or combined with lipopolysaccharide (LPS). In parallel, NCI‐H292 and Calu‐3 cells were co‐cultured under the same conditions. MUC5AC, CXCL8/IL‐8, CXCL1/GRO‐α, and CCL2/MCP‐1 expression was assessed by RT‐qPCR, and protein secretion by ELISA. MUC5AC production in NCI‐H292 was further evaluated by immunohistochemistry. Results In Calu‐3 cells, stimulation had no significant effect on mucin or cytokine expression. In A549 cells, CSE + LPS induced a marked release of CXCL8/IL‐8, CXCL1/GRO‐α, and CCL2/MCP‐1, but no mucus production. In NCI‐H292 cells, LPS alone increased mucus production, and CSE + LPS had an additive effect on both mucins and cytokines (except CCL2/MCP‐1). In NCI‐H292/Calu‐3 co‐cultures, CSE + LPS enhanced MUC5AC gene expression, whereas LPS alone increased CXCL8/IL‐8 secretion. Conclusion Among the tested cell lines, NCI‐H292 displayed the most consistent dual response in terms of mucus and cytokine production. This supports its use as a practical in vitro model for preliminary screening of therapies targeting airway inflammation and mucus hypersecretion.
EUVIMED